Glaxo (GSK) Confirms Offer for Human Genome (HGSI), Deal Valued at $14.25/Share in Cash
Go back to Glaxo (GSK) Confirms Offer for Human Genome (HGSI), Deal Valued at $14.25/Share in Cash| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.88 +1.73 (3.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.15 | 52 Week High | $45.58 | |||
| Open | $51.40 | 52 Week Low | $37.82 | |||
| Day High | $52.95 | P/E | N/A | |||
| Day Low | $51.35 | EPS | $0.00 | |||
| Volume | 3,902,305 | |||||
| Human Genome Sciences, Inc. (NASDAQ: HGSI) | Delayed: 14.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.24 | 52 Week High | $16.58 | |||
| Open | $55.80 | 52 Week Low | $6.51 | |||
| Day High | $14.24 | P/E | N/A | |||
| Day Low | $14.24 | EPS | $-1.79 | |||
| Volume | 557,147 | |||||
